Novocell Hires John West as CEO
Luke Timmerman5/11/09
Novocell, the San Diego-based developer of stem cell therapies for diabetes, said it has named John West as president, CEO , and a member of its board. West was previously CEO of Solexa, a maker of genome sequencing machines that was sold to San Diego-based Illumina (NASDAQ: ILMN) in 2007 for more than $600 million.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
